These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10678604)

  • 1. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy.
    Friedman A; Diamond M; Johnston MV; Daffner C
    Am J Phys Med Rehabil; 2000; 79(1):53-9; quiz 75-6. PubMed ID: 10678604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report.
    Suputtitada A
    Am J Phys Med Rehabil; 2000; 79(4):320-6. PubMed ID: 10892617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection.
    Hurvitz EA; Conti GE; Brown SH
    Arch Phys Med Rehabil; 2003 Mar; 84(3):444-54. PubMed ID: 12638115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
    Mackey AH; Miller F; Walt SE; Waugh MC; Stott NS
    Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
    Park ES; Park CI; Kim DY; Kim YR
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R; Büyükavcı MA
    Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy.
    Wong V; Ng A; Sit P
    J Child Neurol; 2002 Feb; 17(2):138-42. PubMed ID: 11952075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of physical therapy and anti-botulinum toxin antibody on the efficacy of botulinum toxin-A injections in children with spastic cerebral palsy.
    Jang DH; Sung IY
    Dev Neurorehabil; 2014 Dec; 17(6):414-9. PubMed ID: 25372070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
    Rameckers EA; Duysens J; Speth LA; Vles HJ; Smits-Engelsman BC
    J Rehabil Med; 2010 Apr; 42(4):332-8. PubMed ID: 20461335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of botulinum toxin type A treatment in children with spasticity.
    Sarioglu B; Serdaroglu G; Tutuncuoglu S; Ozer EA
    Pediatr Neurol; 2003 Oct; 29(4):299-301. PubMed ID: 14643391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.